BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22038506)

  • 1. Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.
    Jiang W; Wang Z; Li X; Li J; Huang Y; Fan X; Duan Y
    Dig Dis Sci; 2012 Jan; 57(1):92-8. PubMed ID: 22038506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Silencing HMGB1 expression by lentivirus-mediated small interfering RNA (siRNA) inhibits the proliferation and invasion of colorectal cancer LoVo cells in vitro and in vivo].
    Li Z; Wang H; Song B; Sun Y; Xu Z; Han J
    Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):664-70. PubMed ID: 26813430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma.
    Shi W; Su L; Li Q; Sun L; Lv J; Li J; Cheng B
    Tumour Biol; 2014 Oct; 35(10):9627-37. PubMed ID: 24964964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells].
    Li ZJ; Song B; Liu J; Han JJ; Wang CX; Zhu YX; Xu ZF
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):244-8. PubMed ID: 23985250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
    Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
    BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Chen Y; Lin C; Liu Y; Jiang Y
    Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group protein B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-κB.
    Chai Y; Xiao J; Zhang S; Du Y; Luo Z; Zhou X; Huang K
    Int J Mol Med; 2018 Mar; 41(3):1651-1658. PubMed ID: 29328447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
    Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
    Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
    Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
    Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
    Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
    J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
    Li H; Huang W; Luo R
    Diagn Pathol; 2015 Jul; 10():117. PubMed ID: 26194496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
    Wu QF; Liu C; Tai MH; Liu D; Lei L; Wang RT; Tian M; Lü Y
    Acta Pharmacol Sin; 2010 Mar; 31(3):361-6. PubMed ID: 20154714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
    Gan L; Guo K; Li Y; Kang X; Sun L; Shu H; Liu Y
    Oncol Rep; 2010 Apr; 23(4):1037-43. PubMed ID: 20204289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of HMGB1 on invasion and migration of human hepatoma cell line HepG2 and its mechanism].
    Wang C; Tang C; Chang X; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1159-62. PubMed ID: 24200063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calunduloside E inhibits HepG2 cell proliferation and migration via p38/JNK-HMGB1 signalling axis.
    Wang S; Chen X; Cheng J; Cai T; Wu X; Cheng Z; Qi S; Qi Z
    J Pharmacol Sci; 2021 Sep; 147(1):18-26. PubMed ID: 34294368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
    Wang H; Ma D; Wang C; Zhao S; Liu C
    Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
    Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
    Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2.
    Han SX; Zhu Q; Ma JL; Zhao J; Huang C; Jia X; Zhang D
    World J Gastroenterol; 2010 Sep; 16(36):4541-8. PubMed ID: 20857524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.